Olema Oncology to Present Trial-in-Progress Poster for Phase 3 OPERA-02 Trial of Palazestrant Plus Ribociclib at SABCS 2025 GlobeNewswire October 30, 2025 SAN FRANCISCO, Oct. 30, 2025 (GLOBE NEWSWIRE) — Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for breast […]

DBV Technologies Announces Appointment of Philina Lee, Ph.D. to Board of Directors GlobeNewswire October 30, 2025 Chatillon, France, October 30, 2025 DBV Technologies Announces Appointment of Philina Lee, Ph.D. to Board of Directors DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Market: DBVT), (the “Company” or “DBV”), a clinical-stage biopharmaceutical company, today announced the

Riot Platforms Reports Third Quarter 2025 Financial Results and Strategic Highlights GlobeNewswire October 30, 2025 Record quarterly revenue of $180.2 million Net income of $104.5 million, or $0.26 diluted EPS Adjusted EBITDA of $197.2 million Announces initiation of 112 MW of core and shell for data center campus CASTLE ROCK, Colo., Oct. 30, 2025 (GLOBE

Nano Dimension to Host Q3 2025 Financial Results Conference Call Call to Be Held Wednesday, November 19, 2025 at 4:30 PM ET GlobeNewswire October 30, 2025 WALTHAM, Mass., Oct. 30, 2025 (GLOBE NEWSWIRE) — Nano Dimension Ltd. (Nasdaq: NNDM), a leader in digital manufacturing solutions, today announced it will host a conference call and webcast

CN to Report Third-Quarter 2025 Financial and Operating Results Tomorrow GlobeNewswire October 30, 2025 MONTREAL, Oct. 30, 2025 (GLOBE NEWSWIRE) — CN (TSX: CNR) (NYSE: CNI) will issue its third-quarter 2025 financial and operating results at 7:30 a.m. Eastern Time on October 31, 2025. CN's senior officers will review the results and the railway's outlook

(TSX-V:FAIR), VANCOUVER, B.C., Oct. 30, 2025 (GLOBE NEWSWIRE) — via IBN – Fairchild Gold Corp. (“Fairchild” or the “Company“) (TSXV: FAIR, Frankfurt: Y4Y, OTCID: FCHDF), is pleased to announce that it has entered into a Binding Purchase Agreement (“BPA”) dated October 30th , 2025, with a private arm's length party, to acquire a 100% interest

FAIRCHILD COMPLETES A NEVADA TRINITY WITH THE ACQUISITION OF ADVANCED STAGE CARLIN QUEEN PROJECT GlobeNewswire October 30, 2025 VANCOUVER, B.C., Oct. 30, 2025 (GLOBE NEWSWIRE) — via IBN – Fairchild Gold Corp. (“Fairchild” or the “Company“) (TSXV: FAIR, Frankfurt: Y4Y, OTCID: FCHDF), is pleased to announce that it has entered into a Binding Purchase Agreement

https://mma.prnewswire.com/media/405060/Rosen_Law_Logo.jpg Why:Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Quantum Corporation (NASDAQ: QMCO) between November 15, 2024 and August 18, 2025, inclusive (the “Class Period”), of the important November 3, 2025 lead plaintiff deadline in the securities class action first filed by the Firm. So What: If you purchased

“Newark Fashion Forward” and “Newark Chops” to reach national audiences on new entertainment platform Newark Public Schools (NPS) today announced that its two reality series, “Newark Fashion Forward” and Newark Chops, will premiere on In The Black Network (ITBN) on Friday, October 31st, expanding the district's original media productions featuring district students to national audiences

(NASDAQ:MRX), NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) — The Gross Law Firm issues the following notice to shareholders of Marex Group plc (NASDAQ: MRX). Shareholders who purchased shares of MRX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to